title: Seasonal variation in glucocorticoid activity in healthy men.
abstract: Many endocrine systems are subject to seasonal variation. However, studies of the hypothalamic-pituitary-adrenal axis in man have been limited to patients with psychiatric illness with conflicting results. We studied 105 healthy men, age 24-33 yr, during a 15-month period that included two winters. We measured cortisol and its metabolites by gas chromatography/mass spectrometry in plasma and urine and the intensity of dermal blanching after overnight topical application of beclomethasone dipropionate. There were no differences between subjects studied during the two winter periods, but marked differences between subjects studied in winter and summer. In winter, 0900-h plasma cortisol concentrations were higher (73 +/- 10 ng/mL, n = 41 vs. 35 +/- 4, n = 25 in summer; P < 0.01), total cortisol metabolite excretion was lower (678 +/- 67 micrograms/mmol creatinine vs. 900 +/- 98; P < 0.05), the ratio of metabolites of cortisol to those of cortisone was higher (3.0 +/- 0.2 vs. 2.1 +/- 0.1; P < 0.01), and dermal glucocorticoid sensitivity was higher (7.2 +/- 0.4 arbitrary units vs. 5.6 +/- 0.5; P < 0.02). Although blood pressure and fasting insulin/glucose relationships were not measurably different between seasons, these correlated with dermal vasoconstriction and cortisol metabolite excretion rate. We conclude that plasma cortisol and tissue sensitivity to glucocorticoids are higher in winter, but cortisol production rate is reduced. This could be explained by a reduction in cortisol clearance rate: urinary free cortisol/cortisone ratios were not different but A-ring-reduced metabolites of cortisol were higher in winter, suggesting that conversion of cortisone to cortisol by hepatic 11 beta-hydroxysteroid dehydrogenase 1 is enhanced. It is an intriguing possibility that increased glucocorticoid activity contributes to the increased prevalence of disease during the winter.
authors.affiliation: University of Edinburgh, Department of Medicine, Western General Hospital, Scotland, United Kingdom.
authors.forename: B R
authors.initials: BR
authors.lastname: Walker
authors.forename: R
authors.initials: R
authors.lastname: Best
authors.forename: J P
authors.initials: JP
authors.lastname: Noon
authors.forename: G C
authors.initials: GC
authors.lastname: Watt
authors.forename: D J
authors.initials: DJ
authors.lastname: Webb
mesh_terms: D000328:Adult; D001507:Beclomethasone / Q000494:pharmacology; D001786:Blood Glucose / Q000032:analysis; D015331:Cohort Studies; D008401:Gas Chromatography-Mass Spectrometry; D005938:Glucocorticoids / Q000097:blood* / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000097:blood / Q000652:urine; D007333:Insulin Resistance / Q000502:physiology; D008297:Male; D009994:Osmolar Concentration; D012016:Reference Values; D012621:Seasons; D012867:Skin / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology
chemical_list: D001786:Blood Glucose; D005938:Glucocorticoids; D014662:Vasoconstrictor Agents; D001507:Beclomethasone; D006854:Hydrocortisone